Results 251 to 260 of about 1,396,034 (289)

The value of CT texture analysis in predicting mitotic activity and morphological variants of adrenocortical carcinoma. [PDF]

Front Radiol
Tarbaeva NV, Manaev AV, Ivashchenko KV, Platonova NM, Beltsevich DG, Pachuashvili NV, Urusova LS, Mokrysheva NG.   +7 more
europepmc   +1 more source

Multi-omics-based molecular classification of adrenocortical carcinoma predicts response to immunotherapy and targeted treatments. [PDF]

Discov Oncol
Jin X, Wang X, Wang Z, Huang B, Zhou X, Liu B, Shao Y, Lu G.   +7 more
europepmc   +1 more source

PET/CT Findings of a Solid Pseudopapillary Tumor Mimicking Adrenocortical Carcinoma. [PDF]

Clin Nucl Med
Jiang Z, Shan H, Li J, Xiao Y, Zhu X.
europepmc   +1 more source

Adrenocortical carcinoma

, 2019
openaire   +1 more source

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis

Chortis V, Borges KS, Yao C, Ribeiro C, Nagano LF, Berber M, Prete A, Najdekr L, Klontzas ME, Jankevics A, Vendramini P, Kremer JL, Kelley L, Raveenthiraraj S, Tsagarakis S, Macech M, Pupovac ID, Papathomas TG, Haykir B, Winder C, Quinkler M, Dennedy MC, Ueland GÅ, Beuschlein F, Tabarin A, Fassnacht M, Taylor AE, Kastelan D, Ambroziak U, Vassiliadi DA, Kiseljak-Vassiliades K, Bancos I, Carlone DL, Dunn WB, Arlt W, Haigis MC, Breault DT.   +36 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adrenocortical Carcinoma

Journal of Urology, 2008
Adrenocortical carcinoma (ACC) is a rare cancer with a generally poor prognosis. In approximately 60% of cases the initial clinical manifestations are due to hypersecretion of adrenocortical hormones. Cushing's syndrome is the most frequent hormonal manifestation.
Camil J, Chouairy, Fadi, Abdul-Karim, Gregory T, MacLennan   +2 more
  +6 more sources

Adrenocortical carcinoma

Current Opinion in Oncology, 2006
Adrenocortical carcinoma is a rare malignancy, accounting for 0.02% of all annual cancers reported. Given the generally advanced stage at diagnosis, the overall 5-year survival remains poor, varying between 20 and 45%. While older studies purported an improved outcome for functional tumors in adult patients, this has not been borne out in more recent ...
Steven E, Rodgers, Douglas B, Evans, Jeffrey E, Lee, Nancy D, Perrier   +3 more
  +7 more sources

Virilising adrenocortical carcinoma

BMJ Case Reports, 2021
Adrenocortical carcinoma (ACC) is a rare malignancy, with an estimated annual incidence of 0.7–2 cases per million and a median overall survival of 3–4 years. Hormone-secreting ACCs represent most cases; of these, only a small minority presents with virilisation alone. Early diagnosis is key to increase the chances of a better outcome.
Diogo Nunes, Correia, Inês Redondo de, Carvalho, Jeenal Assuani, Mangi   +2 more
openaire   +2 more sources